In Vitro and In Vivo Assessment of Docetaxel Formulation Developed for Esophageal Stents
Authors:
- 19 February 2016
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 18 (1) , 130-137
Abstract
Esophageal cancer (EC) mostly affects the elderly population and is frequently diagnosed at an advanced stage. Self-expanding metal stents (SEMS) are the most popular mode of palliation, but they are associated with reocclusion caused by tumor growth. To overcome this problem, docetaxel (DTX)-loaded polyurethane formulations were prepared for stent application. The films were evaluated against the cancer cell lines, OE-19 and OE-21, and normal esophageal cell line Het-1A. The DTX and the formulations were evaluated in vitro for the cytotoxicity and in vivo in nude mice. It was found that DTX and the formulations have a weak activity against the EC cell lines and an even weaker activity against Het-1A cell line. Preliminary in vivo studies showed skin toxicity in nude mice necessitating modification of the formulation. Reevaluation in a mouse xenograft model resulted in toxicity at high dose formulations while the low dose formulation exhibited modest advantage over commercial IV formulation; however, there was no significant difference between the commercial IV and blank formulation. DTX combination with an anti-cancer agent having complementary mode of action and non-overlapping toxicity could yield better outcome in future.Keywords
This publication has 22 references indexed in Scilit:
- Engineering Stent Based Delivery System for Esophageal Cancer Using DocetaxelMolecular Pharmaceutics, 2015
- Taxanes: vesicants, irritants, or just irritating?Therapeutic Advances in Medical Oncology, 2013
- Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancerInternational Journal of Pharmaceutics, 2012
- Esophageal Stenting in the Setting of MalignancyISRN Gastroenterology, 2011
- An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosisBiomaterials, 2011
- Stenting of the Upper Gastrointestinal Tract: Current StatusCardioVascular and Interventional Radiology, 2010
- Role of Esophageal Stents in Benign and Malignant DiseasesAmerican Journal of Gastroenterology, 2010
- Prevention of Local Tumor Recurrence Following Surgery Using Low-Dose Chemotherapeutic Polymer FilmsAnnals of Surgical Oncology, 2009
- Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagusAdvanced Drug Delivery Reviews, 2006
- Microtubule-targeted anticancer agents and apoptosisOncogene, 2003